6OP Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - OSE Immunotherapeutics SA

Watchlist Manager

Watchlist

Price: 1.992 EUR -2.54% Market Closed

Market Cap: €43.4m

	OSE Immunotherapeutics SA F:6OP	FR
R	Royal Gold Inc F:RG3	US
	Consorcio Ara SAB de CV OTC:CNRFF	MX
P	Polymac Thermoformers Ltd BSE:537573	IN
	Alliance Creative Group Inc OTC:ACGX	US
S	Sigma Lithium Corp NASDAQ:SGML	CA
	Lindian Resources Ltd ASX:LIN	AU
N	NET Detergent JSC VN:NET	VN
	Ralph Lauren Corp NYSE:RL	US
S	Sumitomo Metal Mining Co Ltd F:S19	JP
	Beneteau SA PAR:BEN	FR
	Technip Energies NV F:68F	FR
H	High Templar Tech Ltd F:1QU	CN

Profitability Summary

OSE Immunotherapeutics SA's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-1 359%

Negative 3Y Average Operating Margin

-777%

Declining Operating Margin

-811% > -1 359%

Negative Net Margin

-1 401%

Negative 3Y Average Net Margin

-781%

Declining Net Margin

-769% > -1 401%

Negative Free Cash Flow Margin

-1 268%

Negative 3Y Average Free Cash Flow Margin

-744%

Declining Free Cash Flow Margin

-784% > -1 268%

Negative ROE

-82%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-3%

Declining ROIC

-51% > -70%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.